CN101579328A - 康普立停的用途 - Google Patents

康普立停的用途 Download PDF

Info

Publication number
CN101579328A
CN101579328A CN 200810037243 CN200810037243A CN101579328A CN 101579328 A CN101579328 A CN 101579328A CN 200810037243 CN200810037243 CN 200810037243 CN 200810037243 A CN200810037243 A CN 200810037243A CN 101579328 A CN101579328 A CN 101579328A
Authority
CN
Grant status
Application
Patent type
Prior art keywords
tumor
combretastatin
cancer
weight
formula
Prior art date
Application number
CN 200810037243
Other languages
English (en)
Chinese (zh)
Inventor
沈卫平
王建国
Original Assignee
浙江大德药业集团有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

CN 200810037243 2008-05-12 2008-05-12 康普立停的用途 CN101579328A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200810037243 CN101579328A (zh) 2008-05-12 2008-05-12 康普立停的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200810037243 CN101579328A (zh) 2008-05-12 2008-05-12 康普立停的用途

Publications (1)

Publication Number Publication Date
CN101579328A true true CN101579328A (zh) 2009-11-18

Family

ID=41361736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200810037243 CN101579328A (zh) 2008-05-12 2008-05-12 康普立停的用途

Country Status (1)

Country Link
CN (1) CN101579328A (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途
CN103524349B (zh) * 2013-10-19 2015-09-09 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途

Similar Documents

Publication Publication Date Title
Yang et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata
Ullah Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy
Wu et al. Drug–drug interactions of silymarin on the perspective of pharmacokinetics
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US6410052B1 (en) Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US20050187149A1 (en) Antitumor agent
US20040063648A1 (en) Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
WO1999034796A1 (en) Synergistic antitumor composition containing a naphthalensulphonic acid derivative
CN102178796A (zh) 灯芯草有效组份在制备抗肿瘤或抑制血管生成药物、保健食品或化妆品中的应用
Dozio et al. The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
US6759064B2 (en) Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US6652890B2 (en) Tea catechins as cancer specific proliferation inhibitors
WO2005044182A2 (en) Compositions of botanical extracts for cancer therapy
CN1712399A (zh) 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途
CN1444935A (zh) 表没食子儿茶素没食子酸酯在抗肿瘤药物中应用
Cham Solasodine rhamnosyl glycosides specifically bind cancer cell receptors and induce apoptosis and necrosis. Treatment for skin cancer and hope for internal cancers
Rafi et al. A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylation
WO2006116897A1 (en) Diterpenes from euphorbia kansui and their use
Król et al. Comprehensive review on betulin as a potent anticancer agent
US20040142048A1 (en) Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
US20120045532A1 (en) Anticancer Methods Employing Extracts of Gleditsia sinensis Lam
US20010006983A1 (en) Multicomponent biological vehicle
Wang et al. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: in vivo activity and mechanisms
Dorr Pharmacology of the taxanes
Zang et al. Research progress of ursolic acid’s anti-tumor actions

Legal Events

Date Code Title Description
C06 Publication
C10 Request of examination as to substance
C12 Rejection of an application for a patent